News
-
-
PRESS RELEASE
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma: Preliminary Q2 2025 figures exceed capital market expectations
SCHOTT Pharma AG & Co. KGaA exceeds Q2 2025 expectations with EUR 252m revenues, EUR 72m EBITDA, and 28.6% EBITDA margin, maintaining full-year guidance. Detailed results on May 15, 2025 -
-
-
-
-
PRESS RELEASE
General Meeting of Shareholders of Zug Estates Holding Ltd approves all proposals of the Board of Directors
Zug Estates Holding Ltd's General Meeting of Shareholders approves all proposals by the Board of Directors, including dividend distribution and Board re-elections. Next meeting set on 8 April 2026 -
PRESS RELEASE
ENOGIA: NEEXT ENGINEERING and ENOGIA announce the signing of a Memorandum of Understanding to revolutionise energy yields
NEEXT ENGINEERING and ENOGIA sign MoU for developing reactive fluid technologies to enhance energy yields in heat-to-power conversion and heat pumps, targeting key sectors -
-
PRESS RELEASE
PRESS RELEASE CLOSING OF 2024 ACCOUNTS
The Board of Directors approved the financial statements and consolidated accounts for 2024. Decrease in turnover explained by challenging markets in the Middle East and Asia. Operating income and net income declined. Gévelot SA's financials also reported